Using a chemiluminescence reaction between luminol and H 2 O 2 in basic solution, an ultrasensitive electrochemiluminescence (ECL) aptasensor was developed for the determination of tobramycin (TOB), as an aminoglycoside antibiotic. Ti 3 C 2 /Ni/Sm-LDH-based nanocomposite effectively catalyzes the oxidation of luminol and decomposition of H 2 O 2 , leading to the formation of different reactive oxygen species (ROSs), thus amplifying the ECL signal intensity of luminol, which can be used for the determination of TOB concentration. To evaluate the performance of the electrochemiluminescence aptasensor and synthesized nanocomposite, different methods such as cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) analyses were performed. The considerable specific area, large number of active sites, and enhanced electron transfer reaction on this nanocomposite led to the development of an ECL aptasensor with high sensitivity and electrocatalytic activity. After optimizing the preparation method and analysis conditions, the aptasensor revealed a wide linear response ranging from 1.0 pM to 1.0 μM with a detection limit of 18 pM, displaying outstanding accuracy, specificity, and response stability. The developed ECL sensor was found to be applicable to the determination of TOB in human serum samples and is anticipated to possess excellent clinical potentials for detecting other antibiotics, as well.
Keyphrases
- sensitive detection
- quantum dots
- molecularly imprinted
- solid phase extraction
- energy transfer
- electron transfer
- label free
- reduced graphene oxide
- loop mediated isothermal amplification
- gold nanoparticles
- reactive oxygen species
- particulate matter
- air pollution
- simultaneous determination
- tandem mass spectrometry
- liquid chromatography
- heavy metals
- metal organic framework
- single cell
- high resolution
- polycyclic aromatic hydrocarbons
- magnetic resonance imaging
- pseudomonas aeruginosa
- water soluble
- acinetobacter baumannii
- mass spectrometry
- drug resistant
- risk assessment
- computed tomography
- multidrug resistant
- solid state